Journal of Thrombosis and Thrombolysis

, Volume 35, Issue 3, pp 375–386

The future of inpatient anticoagulation management

Article

DOI: 10.1007/s11239-013-0892-1

Cite this article as:
Burnett, A.E. & Trujillo, T.C. J Thromb Thrombolysis (2013) 35: 375. doi:10.1007/s11239-013-0892-1
  • 483 Downloads

Abstract

Anticoagulation therapy management has evolved dramatically in both the outpatient and inpatient arenas over the last 30 years in the interest of optimizing patient safety and outcomes. With the advent of target specific oral anticoagulants and next generation antiplatelet agents, a new world of “antithrombosis management” is quickly becoming evident. Additionally, significant changes to the healthcare system in the United States are anticipated with the implementation of the Healthcare Affordability Act. Collectively, these changes constitute the next major evolution in the management of patients on antithrombotic therapy. This article is intended to serve as a call to action for inpatient anticoagulation management services and specialists to familiarize themselves with potential changes, consider the impact they may have and proactively optimize their structure and services to be better able to embrace and capitalize on change.

Keywords

Inpatient anticoagulation Healthcare reform Patient self-testing Pharmacogenetic Provider status Target specific oral anticoagulant 

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Clinical Team Lead-Inpatient Anticoagulation ServicesUniversity of New Mexico College of Pharmacy, University of New Mexico HospitalAlbuquerqueUS
  2. 2.C238-V20 Pharmacy & Pharmaceutical SciencesUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, University of Colorado HospitalAuroraUS

Personalised recommendations